Hand Dynamometer and Clinical Tests to Evaluate Neuromuscular Recovery in Atracurium vs Rocuronium
Launched by AL SAFWA UNIVERSITY COLLEGE · Dec 11, 2022
Trial Information
Current as of February 05, 2025
Unknown status
Keywords
ClinConnect Summary
This clinical trial is studying how well patients recover from muscle relaxation after surgery when two different medications, Atracurium and Rocuronium, are used. After general anesthesia, some patients may experience lasting effects from these medications, which can lead to difficulties like trouble breathing or clearing secretions. To better understand recovery, researchers will use a hand dynamometer—a device that measures hand grip strength—along with other simple tests to evaluate how well patients regain their muscle function.
To be part of this study, participants need to be between 18 and 60 years old and classified as ASA II, which means they are generally healthy but may have mild medical issues. Unfortunately, individuals under 18 or over 60 years old, as well as those who have received certain medications, cannot participate. If you join the trial, you can expect to undergo various assessments to measure your muscle recovery after surgery, helping researchers learn which medication leads to better outcomes for patients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • all patient between 18-60 years old with ASAII under general anesthesia
- Exclusion Criteria:
- • all patient under 18 years old and over 60 years old
- • prior administration of suxamethonium
- • patient received magnesium, lithium, Quinidine, calcium channel blockers, local anesthesia
About Al Safwa University College
Al Safwa University College is a leading educational institution dedicated to advancing healthcare research and clinical trials. With a commitment to excellence in medical education and innovation, the college fosters a collaborative environment that supports the development of evidence-based practices. By engaging in clinical trials, Al Safwa University College aims to contribute to the advancement of medical knowledge and improve patient outcomes through rigorous research methodologies and ethical standards. The institution's focus on interdisciplinary collaboration ensures a comprehensive approach to addressing pressing health challenges in the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Najaf, Adala, Iraq
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials